The (POGO) Blog
March 3, 2017
President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.
February 22, 2017
The Food and Drug Administration has a brand-new policy bringing greater transparency regarding the agency's advisory committee members. The increased transparency will help address concerns over these members' conflicts of interest and the advice they giv
February 17, 2017
POGO Investigator Lydia Dennett explains the loopholes in the Foreign Agents Registration Act and the Lobbying Disclosure Act that could allow lobbying agents with foreign clients to get around President Trump's foreign lobbying ban.
February 13, 2017
By Sean Moulton
The Project On Government Oversight and the National Security Archive are seeking the input of anyone that has requested government agency records through the Freedom of Information Act (FOIA). The survey is open until the end of February. Results will be used to inform the work of the FOIA Federal Advisory Committee.
Topics: Open Government